Inventor · disambiguated record
Sanjay Khare
Also filed as: KHARE SANJAY · KHARE SANJAY D · KHARE SANJAY K
12 granted patents·7 pending applications·346 citations·filing 2003–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0198US10077300B2Activatable binding polypeptides and methods of identification and use thereofUNIV CALIFORNIA·Filed 2015·Granted Sep 18, 2018·42 cites·36 claims
- 0297US9169321B2Activatable binding polypeptides and methods of identification and use thereofUNIV CALIFORNIA·Filed 2013·Granted Oct 27, 2015·62 cites·41 claims
- 0396US8518404B2Activatable binding polypeptides and methods of identification and use thereofDAUGHERTY PATRICK·Filed 2012·Granted Aug 27, 2013·105 cites·25 claims
- 0494US11028162B2Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moietiesUNIV CALIFORNIA·Filed 2018·Granted Jun 8, 2021·6 cites·27 claims
- 0594US8980267B2Engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2013·Granted Mar 17, 2015·69 cites·24 claims
- 0691US9534056B2Engineered TAA antibody-TNFSF member ligand fusion moleculesGREWAL IQBAL·Filed 2012·Granted Jan 3, 2017·37 cites·9 claims
- 0791US7928074B2Combination therapy with co-stimulatory factorsAMGEN INC·Filed 2008·Granted Apr 19, 2011·18 cites·15 claims
- 0883US9783589B2Engineered antibody-interferon fusion molecules for treatment of autoimmune diseasesIMMUNGENE INC·Filed 2013·Granted Oct 10, 2017·5 cites·9 claims
- 0980US7579316B2Compositions and methods to modulate an immune response to an immunogenic therapeutic agentAMGEN INC·Filed 2005·Granted Aug 25, 2009·1 cites·21 claims
- 1079US12209120B2Activatable anti-VEGF scFvUNIV CALIFORNIA·Filed 2021·Granted Jan 28, 2025·0 cites·3 claims
- 1168US9534057B2Methods of treating tumors with engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2015·Granted Jan 3, 2017·1 cites·10 claims
- 1268US2009304719A1Activatable binding polypeptides and methods of identification and use thereofDAUGHERTY PATRICK·Filed 2008·Application pending·0 cites
- 1364US2025197500A1Methods of treating cancerCOHERUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1456US10259854B2Engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2016·Granted Apr 16, 2019·0 cites·12 claims
- 1550US2004208874A1Combination therapy with co-stimulatory factorsFiled 2003·Application pending·0 cites
- 1650US2009226435A1Engineered fusion molecules immunotherapy in cancer and inflammatory diseasesKHARE SANJAY·Filed 2009·Application pending·0 cites
- 1741US2018312561A1Focused interferon immunotherapy for treatment of cancerIMMUNGENE INC·Filed 2016·Application pending·0 cites
- 1841US2006002929A1Monoclonal antibodiesKHARE SANJAY D·Filed 2005·Application pending·0 cites
- 1940US2006160989A1Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereofCOUNCIL OF SCIENTIC AND IND RE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanjay Khare files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →